Partner closely with Research, Clinical Data Management, Biostatistics, Commercial and other business functions to identify opportunities to leverage AI for improving data, processing, analytics, integration, quality, visualization, and competitive insights, and commercial intelligence, accelerating research, clinical development, and evidence-based decision-making across the organization. HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.